Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 16.34%14.91M | 0.97%13.69M | -6.27%13.97M | 29.24%56.19M | 3.19%13.56M | 29.58%14.9M | 42.36%14.91M | 21.90%12.81M | 20.96%43.48M | 37.72%13.14M |
| Cost of revenue | 15.58%3.34M | 6.30%2.99M | -16.18%2.92M | 26.56%12.67M | -1.06%2.81M | 31.76%3.49M | 59.67%3.48M | 23.30%2.89M | 8.09%10.01M | 39.13%2.84M |
| Gross profit | 16.57%11.57M | -0.42%10.7M | -3.25%11.05M | 30.03%43.52M | 4.36%10.74M | 28.93%11.42M | 37.81%11.43M | 21.50%9.92M | 25.43%33.47M | 37.34%10.3M |
| Operating expense | 16.52%8.6M | -55.45%4.3M | 1.24%7.09M | 16.53%31.25M | 9.42%9.66M | 7.15%7M | 24.13%7.21M | 30.60%7.38M | 20.82%26.81M | 15.21%8.83M |
| Selling and administrative expenses | 16.52%8.6M | -55.45%4.3M | 1.24%7.09M | 16.55%31.25M | 9.42%9.66M | 7.15%7M | 24.13%7.21M | 30.60%7.38M | 20.80%26.81M | 15.21%8.83M |
| -General and administrative expense | 16.52%8.6M | -55.45%4.3M | 1.24%7.09M | 16.55%31.25M | 9.42%9.66M | 7.15%7M | 24.13%7.21M | 30.60%7.38M | 20.80%26.81M | 15.21%8.83M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3K | ---- |
| Operating profit | 16.71%2.97M | 488.50%6.4M | -10.36%3.96M | 84.46%12.27M | -26.00%1.09M | 90.11%4.42M | 69.81%4.22M | 1.07%2.54M | 48.22%6.65M | 990.30%1.47M |
| Net non-operating interest income (expenses) | -449.29%-1.16M | -31.65%-782K | -9.08%-817K | -1,490.24%-1.96M | -980.00%-594K | -1,460.42%-749K | -2,771.43%-402K | -2,914.29%-211K | -173.33%-123K | -400.00%-55K |
| Non-operating interest expense | 449.29%1.16M | 31.65%782K | 9.08%817K | 1,490.24%1.96M | 980.00%594K | 1,460.42%749K | 2,771.43%402K | 2,914.29%211K | 173.33%123K | 400.00%55K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 0 | 0 | |||||||
| Other non-operating income (expenses) | 474.53%609K | -105.41%-2.41M | -57.03%-592K | 978.65%45.37M | 5,251.32%44.52M | -135.60%-377K | 1,016.00%1.12M | 45.21%106K | 126.37%4.21M | 49.64%832K |
| Income before tax | -0.86%2.42M | -92.88%3.21M | -22.50%2.55M | 418.70%55.68M | 1,904.27%45.02M | -1.26%3.29M | 91.91%4.93M | -5.57%2.44M | 58.10%10.74M | 281.32%2.25M |
| Income tax | 16.45%1.15M | -149.41%-2.37M | -18.79%1M | 157.13%8.79M | 536.21%4.8M | 11.97%1.24M | 89.46%1.76M | 57.05%991K | 789.84%3.42M | 153.90%754K |
| Net income | -12.71%1.26M | -86.14%5.58M | -24.72%1.55M | 540.83%46.9M | 2,595.64%40.22M | -7.79%2.06M | 93.17%3.17M | -25.82%1.45M | 14.24%7.32M | -24.95%1.49M |
| Net income continuous operations | -12.71%1.26M | -86.14%5.58M | -24.72%1.55M | 540.83%46.9M | 2,595.64%40.22M | -7.79%2.06M | 93.17%3.17M | -25.82%1.45M | 14.24%7.32M | -24.95%1.49M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net income attributable to the company | -12.71%1.26M | -86.14%5.58M | -24.72%1.55M | 540.83%46.9M | 2,595.64%40.22M | -7.79%2.06M | 93.17%3.17M | -25.82%1.45M | 14.24%7.32M | -24.95%1.49M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -12.71%1.26M | -86.14%5.58M | -24.72%1.55M | 540.83%46.9M | 2,595.64%40.22M | -7.79%2.06M | 93.17%3.17M | -25.82%1.45M | 14.24%7.32M | -24.95%1.49M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -16.90%0.0059 | -86.15%0.0275 | -25.49%0.0076 | 541.00%0.2314 | 2,582.43%0.1985 | -7.27%0.0102 | 92.59%0.0156 | -26.04%0.0071 | 14.24%0.0361 | -24.49%0.0074 |
| Diluted earnings per share | -16.90%0.0059 | -86.15%0.0275 | -25.49%0.0076 | 541.00%0.2314 | 2,582.43%0.1985 | -7.27%0.0102 | 92.59%0.0156 | -26.04%0.0071 | 14.24%0.0361 | -24.49%0.0074 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.